メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
藤田医科大学でコンテンツを検索
ホーム
プロファイル
研究部門
研究成果
受賞
L-tryptophan-kynurenim pathway enzymes are a therapeutic target for various neurological disorders
Kuniaki Saito
研究成果
:
ジャーナルへの寄稿
›
総説
›
査読
概要
フィンガープリント
フィンガープリント
「L-tryptophan-kynurenim pathway enzymes are a therapeutic target for various neurological disorders」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Tryptophan
100%
Therapeutic Target
100%
Neurological Disorders
100%
Blood-brain Barrier
44%
Metabolism
33%
Kynurenine Pathway
33%
Kynurenine
33%
Systemic Administration
11%
Indoleamine 2,3-dioxygenase 1 (IDO1)
11%
Novel Therapeutics
11%
Inflammatory Cytokines
11%
Albumin
11%
Depressive Symptoms
11%
Physiological Significance
11%
Rate Limiting
11%
Cytokine Therapy
11%
Freeform
11%
Immune Regulation
11%
3-hydroxyanthranilic Acid
11%
Immune Function
11%
Enzyme Modulators
11%
Neurodegenerative Effects
11%
Cognitive Effects
11%
Inflammatory CNS Disease
11%
Immune Stress
11%
Secondary Changes
11%
Inducible Enzymes
11%
Neuroscience
Tryptophan
100%
Nervous System Disorder
100%
Enzymes
100%
Kynurenine
66%
Blood Brain Barrier
44%
Metabolic Pathway
33%
Cytokine
22%
Indoleamine 2,3 Dioxygenase
11%
3 Hydroxyanthranilic Acid
11%
Enzyme Modulator
11%
Blood Plasma
11%
Albumin
11%
Biochemistry, Genetics and Molecular Biology
Enzyme
100%
Tryptophan
100%
Blood Brain Barrier
44%
Metabolic Pathway
33%
Kynurenine Pathway
33%
Kynurenine
33%
Cytokine
11%
Indoleamine 2,3-dioxygenase
11%
Inflammatory Cytokine
11%
Immunoregulation
11%
Blood Plasma
11%
Albumin
11%
Pharmacology, Toxicology and Pharmaceutical Science
Tryptophan
100%
Enzymes
100%
Kynurenine
66%
Blood-Brain Barrier
44%
Cytokine
22%
Systemic Administration
11%
Indoleamine 2,3 Dioxygenase
11%
Central Nervous System Disease
11%
3 Hydroxyanthranilic Acid
11%
Enzyme Modulator
11%
Albumin
11%